{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:33Z","timestamp":1761562053807,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.carrev.2016.12.014","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T09:32:07Z","timestamp":1482053527000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement"],"prefix":"10.1016","volume":"18","author":[{"given":"Joshua M.","family":"Stolker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne V.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.12.014_bb0005","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: executive summary","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0010","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCA.0b013e3282f34220","article-title":"Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'","volume":"19","author":"Jeremias","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2016.12.014_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.110.978593","article-title":"Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry","volume":"124","author":"Venkitachalam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0025","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIRCULATIONAHA.107.725531","article-title":"Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents","volume":"117","author":"Hannan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0030","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"JV","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0035","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.297.18.1992","article-title":"Outcomes and complications associated with off-label and untested use of drug-eluting stents","volume":"297","author":"Beohar","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.12.014_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa0706258","article-title":"A comparison of bare-metal and drug-eluting stents for off-label indications","volume":"358","author":"Marroquin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0045","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.297.18.2001","article-title":"Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents","volume":"297","author":"Win","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.12.014_bb0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjcard.2007.11.074","article-title":"Four-year clinical follow-up of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital registry","volume":"101","author":"Daemen","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.CIR.0000109138.84579.FA","article-title":"Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the \u201creal world\u201d: the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.946939","article-title":"Predicting restenosis in drug eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry","volume":"3","author":"Stolker","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0065","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.111.045229","article-title":"Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention","volume":"124","author":"Yeh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","article-title":"Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes","volume":"92","author":"Hong","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2016.12.014_bb0075","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.CIR.0000131898.18849.65","article-title":"Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"109","author":"Singh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijcard.2007.02.031","article-title":"Safety and efficacy of the cypher select sirolimus-eluting stent in the \u201creal world\u201d\u2014clinical and angiographic results from the China Cypher Select registry","volume":"125","author":"Gao","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0085","first-page":"821","article-title":"Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries","volume":"69","author":"Lee","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2005.03.030","article-title":"Design of a registry to characterize \u201creal-world\u201d outcomes of percutaneous coronary revascularization in the drug-eluting stent era","volume":"150","author":"Jacob","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2016.12.014_bb0095","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall c as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0100","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1081\/STA-200026579","article-title":"Inference on correlated discrimination measures in survival analysis: a nonparametric approach","volume":"33","author":"Antolini","year":"2004","journal-title":"Commun Stat Theory Methods"},{"key":"10.1016\/j.carrev.2016.12.014_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCIMAGING.112.000158","article-title":"Usefulness of exercise test and myocardial perfusion-gated single photon emission computed tomography to improve the prediction of major events","volume":"6","author":"Candell-Riera","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2016.12.014_bb0115","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2010111163","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0120","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.2215\/CJN.04960511","article-title":"Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis","volume":"6","author":"Hall","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cardfail.2014.06.001","article-title":"Incremental utility of iodine-123 meta-iodobenzylguanidine imaging beyond established heart failure risk models","volume":"20","author":"Jain","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.carrev.2016.12.014_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-150-2-200901200-00003","article-title":"Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3","volume":"150","author":"Paynter","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jacc.2010.01.061","article-title":"Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction >35%","volume":"56","author":"Piccini","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.CIR.0000155242.70417.60","article-title":"Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery","volume":"111","author":"Spertus","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0145","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0150","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0735-1097(01)01431-0","article-title":"Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era","volume":"38","author":"Mercado","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0160","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jacc.2010.08.608","article-title":"Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction) trial","volume":"56","author":"Stone","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jcin.2009.05.016","article-title":"In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents","volume":"2","author":"Nowack","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0170","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCINTERVENTIONS.111.967802","article-title":"Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year","volume":"5","author":"Stolker","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0175","first-page":"894","article-title":"Drug-eluting stent in saphenous vein graft lesions","volume":"71","author":"Kornowski","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2008.04.041","article-title":"Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts","volume":"102","author":"Okabe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2007.05.010","article-title":"Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial","volume":"50","author":"Vermeersch","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(11)61255-5","article-title":"Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial","volume":"378","author":"Mehilli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2016.12.014_bb0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jvs.2013.01.010","article-title":"Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting","volume":"58","author":"Bensley","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2016.12.014_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.athoracsur.2012.08.074","article-title":"Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations","volume":"95","author":"Pasquali","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2016.12.014_bb0205","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2012.404","article-title":"Finding pure and simple truths with administrative data","volume":"307","author":"Vaughan Sarrazin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.12.014_bb0210","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.12.014_bb0215","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients: the PURSUIT Investigators","volume":"101","author":"Boersma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0225","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.12.014_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-6-18","article-title":"Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis","volume":"6","author":"Hayward","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.carrev.2016.12.014_bb0240","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.12.014_bb0245","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741","article-title":"Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry","volume":"2","author":"Mehta","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0250","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","article-title":"Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry","volume":"55","author":"Peterson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.12.014_bb0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCOUTCOMES.108.791863","article-title":"Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making","volume":"1","author":"Arnold","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.carrev.2016.12.014_bb0260","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1748-5908-3-58","article-title":"Implementing an innovative consent form: the PREDICT experience","volume":"3","author":"Decker","year":"2008","journal-title":"Implement Sci"},{"key":"10.1016\/j.carrev.2016.12.014_bb0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","author":"The Bypass Angioplasty Revascularization Investigation (BARI) Investigators","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0270","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"For the SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0275","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"For the FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCINTERVENTIONS.113.000679","article-title":"Angiographic validation of the ACCF-STS Collaboration on the Comparative Effectiveness of Revascularization Strategies study","volume":"7","author":"Chakrabarti","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.12.014_bb0285","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Bonaa","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0290","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.12.014_bb0295","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1year results of a randomised controlled trial","volume":"380","author":"Sabat\u00e9","year":"2012","journal-title":"Lancet"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916303505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916303505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:11:32Z","timestamp":1761559892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916303505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1553838916303505"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.12.014","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}